Purinergic P1 Receptor Antagonists
"Purinergic P1 Receptor Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that bind to and block the stimulation of PURINERGIC P1 RECEPTORS.
| Descriptor ID |
D058915
|
| MeSH Number(s) |
D27.505.519.625.725.400.100 D27.505.696.577.725.400.100
|
| Concept/Terms |
Purinergic P1 Receptor Antagonists- Purinergic P1 Receptor Antagonists
- P1 Purinoceptor Antagonists
- Antagonists, P1 Purinoceptor
- Purinoceptor Antagonists, P1
- Adenosine Receptor Antagonists
- Antagonists, Adenosine Receptor
- Receptor Antagonists, Adenosine
|
Below are MeSH descriptors whose meaning is more general than "Purinergic P1 Receptor Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Purinergic P1 Receptor Antagonists".
This graph shows the total number of publications written about "Purinergic P1 Receptor Antagonists" by people in this website by year, and whether "Purinergic P1 Receptor Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Purinergic P1 Receptor Antagonists" by people in Profiles.
-
Mundell SJ, Olah ME, Panettieri RA, Benovic JL, Penn RB. Regulation of G protein-coupled receptor-adenylyl cyclase responsiveness in human airway smooth muscle by exogenous and autocrine adenosine. Am J Respir Cell Mol Biol. 2001 Feb; 24(2):155-63.
-
Gottlieb SS, Skettino SL, Wolff A, Beckman E, Fisher ML, Freudenberger R, Gladwell T, Marshall J, Cines M, Bennett D, Liittschwager EB. Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure. J Am Coll Cardiol. 2000 Jan; 35(1):56-9.
-
D'Ancona S, Ragazzi E, Fassina G, Mazzo M, Gusella M, Berti T. Effect of dipyridamole, 5'-(N-ethyl)-carboxamidoadenosine and 1,3-dipropyl-8-(2-amino-4-chlorophenyl)-xanthine on LOVO cell growth and morphology. Anticancer Res. 1994 Jan-Feb; 14(1A):93-7.